FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40926111000001107: Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Aug 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2420981000001114 Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2420991000001111 Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Has AMP Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Is a Erythromycin stearate 500mg tablets 100 tablet true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Has excipient Tartrazine stain false Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Has specific active ingredient Erythromycin stearate true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythromycin stearate 500mg tablets (Ennogen Pharma Ltd) 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start